DRAVP
  1. Home
  2. Browse
  3. Classified Browse
  4. Back
DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01420 SARSWW-Vb(1169-1194) AACEVAKNLNESLIDLQELGKYEQYIKW SARS-CoV 16616792
DRAVPe01421 MHVWW-IV(1144-1162) GYFVQDDGEWKFTGSSYYY SARS-CoV 16616792
DRAVPe01550 BMAP-28 (BMAP28, bovine myeloid antimicrobial peptide 28; natural AMPs; cathelicidin-5, cattle, ruminant, mammals, animals; BBMm;ZZP; UCLL1; Derivatives: mBMAP-28 GGLRSLGRKILRAWKKYGPIIVPIIRIG HSV,PRCV 15019203
DRAVPe01627 P1(ACE2 (4-13)) EEQAKTFLDK SARS-CoV 16510163
DRAVPe01628 P2(ACE2 (12-20)) DKFNHEAED SARS-CoV 16510163
DRAVPe01629 P3(ACE2 (15-23)) NHEAEDLFY SARS-CoV 16510163
DRAVPe01630 P4(ACE2 (4-26)) EEQAKTFLDKFNHEAEDLFYQSS SARS-CoV 16510163
DRAVPe01631 P5(ACE2 (4-39)) EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE SARS-CoV 16510163
DRAVPe01632 P6(ACE2 (4-26)-G-ACE2 (333-339)) EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR SARS-CoV 16510163
DRAVPe01653 Peptide 2 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01654 Peptide 3 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01655 Peptide 4 GGVLVQPG SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01656 Peptide 5 GVLVQ SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01657 Peptide 6 GVLV SARS-CoV-2,HCMV,VZV 34502335
DRAVPe01712 HKU4-HR2P1 GPNFAEISKINTTLLDLSDEMAMLLQEVVKQLNDSYI MERS-CoV 30646495
DRAVPe01713 HKU4-HR2P2 EISKINTTLLDLSDEMAMLLQEVVKQLNDSYIDLKEL MERS-CoV 30646495
DRAVPe01714 HKU4-HR2P3 LDLSDEMAMLLQEVVKQLNDSYIDLKELGNYTYYNKW MERS-CoV 30646495
DRAVPe01715 MERS-HR2P GGGSLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL MERS-CoV 30646495
DRAVPe01722 P1(SARS-CoV (1153-1189)) GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE SARS-CoV 18983873,15043961
DRAVPe01723 P4(SARS-CoV (1153–1182)) GINASVVNIQKEIDRLNEVAKNLNESLIDL SARS-CoV 18983873
DRAVPe01724 P6(SARS-CoV (1153–1175)) GINASVVNIQKEIDRLNEVAKNL SARS-CoV 18983873
DRAVPe01725 N46(SARS-CoV (902-947)) QKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ SARS-CoV 18983873
DRAVPe01726 N46eg(SARS-CoV (902-947)[K2N,I4S,N9Q,A11E,Q16N,S18V,S23N,A25S,V32D,A37N,A39S,V44Q,Q46E]) QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE SARS-CoV 18983873
DRAVPe01727 SARS-CoV-S (215-232), peptide 9626 TLKPIFKLPLGINITNFR SARS-CoV PsV 19853613
DRAVPe01728 SARS-CoV (770-788)[Y771W] MWKTPTLKYFGGFNFSQIL SARS-CoV 16616792
DRAVPe01729 SARS-CoV (864-886) ATAGWTFGAGAALQIPFAMQMAY SARS-CoV 16616792
DRAVPe01730 SARS-CoV (1028–1049)[Y1049W] GYHLMSFPQAAPHGVVFLHVTW SARS-CoV 16616792
DRAVPe01731 SARS-CoV (1075–1093) GVFVFNGTSWFITQRNFFS SARS-CoV 16616792
DRAVPe01732 AAC-SARS-CoV (1170–1194) AACEVAKNLNESLIDLQELGKYEQYIKW SARS-CoV 16616792
DRAVPe01735 SARS-Cov-S (899-926) YENQKQIANQFNKAISQIQESLTTTSTA SARS-CoV PsV 18442051
First 8 2 3 4 5 6 7 8 Last
CC0 To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.